Italian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
12 risultati
Inhibitors of the renal outer medullary potassium channel
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
The Renal Outer Medullary Potassium (ROMK) channel (Kir1.1) (see e.g., Ho, K., et al., Cloning and expression of an inwardly rectifying ATP-regulated potassium channel, Nature, 1993, 362(6415): p. 31-8.1, 2; and Shuck, M. E., et al., Cloning and characterization of
Methods of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
The present invention relates to novel methods for the treatment or prevention of glaucoma, ocular hypertension, and other ophthalmic disorders exhibiting elevated intraocular pressure, as well as ocular disorders characterized by retinal neurodegeneration or edema including
Methods of treatment using exendin peptides or GLP-1 peptides
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
The present invention relates to methods for increasing urine flow comprising administration of an effective amount of glucagon-like peptide-1 [7-36] amide (abbreviated "GLP-[7-36]NH.sub.2" or simply "GLP-1"), an exendin, or an exendin or GLP-1 agonist. Methods for increasing
Methods of treatment using exendin peptides or GLP-1 peptides
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
The present invention relates to methods for increasing urine flow comprising administration of an effective amount of glucagon-like peptide-1 [7-36] amide (abbreviated "GLP-[7-36]NH.sub.2" or simply "GLP-1"), an exendin, or an exendin or GLP-1 agonist. Methods for increasing
Inotropic and diuretic effects of exendin and GLP-1
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
The present invention relates to methods for increasing urine flow comprising administration of an effective amount of glucagon-like peptide-1[7-36] amide (abbreviated "GLP-[7-36]NH.sub.2 " or simply "GLP-1"), an exendin, or an exendin or GLP-1 agonist. Methods for increasing
Inotropic and diuretic effects of GLP-1 and GLP-1 agonists
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
The present invention relates to methods for increasing urine flow comprising administration of an effective amount of glucagon-like peptide-1[7-36] amide (abbreviated "GLP-[7-36]NH.sub.2" or simply "GLP-1"), an exendin, or an exendin or GLP-1 agonist. Methods for increasing
Artificial cerebrospinal fluid
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The present invention relates to an artificial cerebrospinal fluid, particularly used in the fields of intracranial surgery and neurosurgery for the purpose of irrigation or perfusion, or replenishing lost cerebrospinal fluid, a packaged container holding the artificial cerebrospinal
Electrical producing creams
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is broadly concerned with improved electrical producing creams in forms of creams, lotions, gels or solids which are useful in the treatment of a variety of conditions that are ameliorated by increased cell metabolism,
Aldosterone-antagonistic steroids
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to steroid derivatives having aldosterone-antagonistic activity more potent than that of spironolactone.
2. Description of the Prior Art
The aldosterone antagonists have widely been used alone in diagnosis and
Topical medicament
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is broadly concerned with improved topical medicaments in forms of creams or lotions which are useful in the treatment of a variety of conditions that are ameliorated by increased cell metabolism, circulation, and nerve
Topical medicament
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is broadly concerned with improved topical medicaments in forms of creams or lotions which are useful in the treatment of a variety of conditions that are ameliorated by increased cell metabolism, circulation, and nerve
Composition for the treatment of joint conditions
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The present invention, in some embodiments thereof, relates to health and natural products. Specifically it relates to products to improve the structure and function of diseased articulations (joints) of the body by alleviating articular (joint) pain, inflammation and
Il database di erbe medicinali più completo supportato dalla scienza
- Funziona in 55 lingue
- Cure a base di erbe sostenute dalla scienza
- Riconoscimento delle erbe per immagine
- Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
- Leggi le pubblicazioni scientifiche relative alla tua ricerca
- Cerca le erbe medicinali in base ai loro effetti
- Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti
Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate
